Sector revisions WuXi Biologics (Cayman) Inc. OTC Markets
Stocks
WXXW.Y
US98260N1081
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.620 USD | +0.26% |
|
-7.19% | -4.75% |
| Jun. 05 | Wuxi Biologics Completes Topping Out of Drug Product Facility At Singapore Crdmo Hub | CI |
| May. 31 | Wuxi Biologics adds 69 projects in Jan-April, maintains expected revenue growth | RE |
Main competitors
| 1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Visibility | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|
 | 15 | |||||||
| 16 | |||||||
| 19 | |||||||
| 21 | |||||||
| 15 | |||||||
| 16 | |||||||
| 6 | |||||||
| 17 | |||||||
| 13 | |||||||
| 14 | |||||||
| 20 | |||||||
| 12 | |||||||
| 17 | |||||||
| 20 | |||||||
| 3 | |||||||
| 15 | |||||||
| 20 | |||||||
| - | 1 | ||||||
| 9 | |||||||
| Average | 14 | |||||||
| Weighted average by Cap. | 15 |
Select your edition
All financial news and data tailored to specific country editions
